TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23524151

Group type: EXPERIMENTAL
Intervention: 0-week shoulder motion restriction band
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 3-week shoulder motion restriction band
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 6-week shoulder motion restriction band
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Contact sports
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Noncontact sports
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: No sport activities
Number of subjects: 109
Study: 21496977

Group type: EXPERIMENTAL
Intervention: Removable cast walker boot (n=12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Total contact cast (n=11)
Number of subjects: 23
Study: 19840530

Group type: COMPARATOR
Intervention: EREM alone
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Test dose + flush + 3-minute wait + EREM
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Test dose + flush + 10-minute wait + EREM
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Test dose + flush + 15-minute wait + EREM
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Test dose + 3-minute wait + EREM
Number of subjects: 39
Study: 18473974

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 15230080

Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 16
Study: 11211199

Group type: EXPERIMENTAL
Intervention: Pretransplant erythropoietin treatment aimed at reaching a normal hemoglobin concentration (Hb) (135-160 g/liter)
Number of subjects: 416

Group type: COMPARATOR
Intervention: EPO treatment aimed at maintaining subnormal Hb (90-120 g/liter)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Both groups (normal Hb and subnormal Hb)
Number of subjects: 416
Study: 9484928

Group type: EXPERIMENTAL
Intervention: Standard approach (SVC catheter via subclavian/internal jugular vein or cephalic/external jugular vein cut-down)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Alternative approach (SVC catheter on forearm via basilic vein cut-down and IVC catheter in abdominal region via great saphenous vein cut-down)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Standard approach
Number of subjects: 158

Group type: COMPARATOR
Intervention: Alternative approach
Number of subjects: 158
Study: 8592965

Group type: EXPERIMENTAL
Intervention: S-(+)-ketamine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 40
Study: 2552067

Group type: EXPERIMENTAL
Intervention: HA/TTC (Periograf/tetracycline)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: b‐TCP/TTC (Synthograft/tetracycline)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FDBA/TTC (freeze‐dried bone allograft/tetracycline)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All graft materials (HA/TTC, b‐TCP/TTC, FDBA/TTC)
Number of subjects: 10
Study: 104349

Group type: EXPERIMENTAL
Intervention: 0.414 g ethanol/kg body weight
Number of subjects: 40

Group type: COMPARATOR
Intervention: No alcohol (control group)
Number of subjects: 40
Study: 31442105

Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 0
Study: 30376051

Group type: EXPERIMENTAL
Intervention: Uninterrupted DOAC strategy (UG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Interrupted by one dose strategy (IG)
Number of subjects: 200
Study: 28403523

Group type: EXPERIMENTAL
Intervention: Full surface ablation at 209 μm
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Full surface ablation at 144 μm
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fractional ablation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study: 27330157

Group type: EXPERIMENTAL
Intervention: 4‐1BB ligand and Gal‐9 co-incubation with stimulated mononuclear cells
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: ADAM17 inhibitor
Number of subjects: 109

Group type: COMPARATOR
Intervention: Plasma levels of s4‐1BB
Number of subjects: 109

Group type: COMPARATOR
Intervention: Baseline plasma levels of s4‐1BB
Number of subjects: 109

Group type: COMPARATOR
Intervention: DAS28-CRP
Number of subjects: 109
Study: 23834346

Group type: EXPERIMENTAL
Intervention: Condition one (CS+ 'part') with 12 aversive US images
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Condition two (CS+ 'some') with 12 aversive US images
Number of subjects: 103

Group type: COMPARATOR
Intervention: CS- 'cylinder' with 12 neutral images
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Disgust propensity (DP)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Negative affective responding to the US
Number of subjects: 103
Study: 20549501

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg once daily
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg once daily
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Paracetamol 300 mg three times daily
Number of subjects: 168
Study: 19576311

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (OMT) + percutaneous coronary intervention (PCI)
Number of subjects: 2287

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 2287
Study: 17493468

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DESs)
Number of subjects: 1520

Group type: COMPARATOR
Intervention: Bare Metal Stents (BMSs)
Number of subjects: 1520
Study: 15271744

Group type: EXPERIMENTAL
Intervention: Inversion (I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Plantar flexion (PF)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Eversion (E)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dorsiflexion (DF)
Number of subjects: 100
Study: 11287381

Group type: EXPERIMENTAL
Intervention: Healthy subjects
Number of subjects: 43

Group type: COMPARATOR
Intervention: Spastic patients
Number of subjects: 43
Study: 8882469

Group type: EXPERIMENTAL
Intervention: 12 cycles of low-dose CMF (100 mg CPA orally on days 1 to 14, 20 mg MTX and 500 mg 5-FU intravenously on days 1 and 8 of each cycle)
Number of subjects: 176

Group type: COMPARATOR
Intervention: CPA plus FT (100 mg CPA and 600 mg FT orally each day for one year)
Number of subjects: 176
Study: 1985045

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (nontreated)
Number of subjects: 32
Study: 6841947

Group type: EXPERIMENTAL
Intervention: Patients with common duct stones and recurrent pancreatitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31200828

Group type: EXPERIMENTAL
Intervention: Selumetinib (intermittent schedule on days 2–19)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Selumetinib (continuous schedule on days 1–21)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 62
Study: 26194113

Group type: EXPERIMENTAL
Intervention: Psychosocial Post-Discharge Intervention Program delivered by social workers
Number of subjects: 3
Study: 27927660

Group type: EXPERIMENTAL
Intervention: Prehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60
Study: 24197291

Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (1.0 μg/kg/min)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.25 μg/kg/min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: TEA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 22683399

Group type: EXPERIMENTAL
Intervention: Caregiver's own PIM use
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Spouse caregivers
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Hispanic caregivers
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Greater number of years that the caregiver has lived in the United States
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Increased caregiver age
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: PIM use in dementia patients
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: PIM use in caregivers
Number of subjects: 566
Study: 19438730

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 571
Study: 17822506

Group type: EXPERIMENTAL
Intervention: Eflornithine 13.9% cream
Number of subjects: 0
Study: 15537680

Group type: EXPERIMENTAL
Intervention: Occupational therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social work
Number of subjects: 0
Study: 12510955

Group type: EXPERIMENTAL
Intervention: Symbicort® (budesonide and formoterol in a single inhaler)
Number of subjects: 0
Study: 9797624

Group type: EXPERIMENTAL
Intervention: r‐HuEPO and iron (EPO + iron), 1200 IU/kg/week of r‐HuEPO plus 20 mg/kg/week of intravenous iron
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: r‐HuEPO alone (EPO), 1200 IU/kg/week
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: EPO + iron
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: EPO
Number of subjects: 63
Study: 7613894

Group type: EXPERIMENTAL
Intervention: 5000 XaI units of dalteparin
Number of subjects: 2070

Group type: COMPARATOR
Intervention: 2500 XaI units of dalteparin
Number of subjects: 2070
Study: 2179780

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation plus less ibuprofen
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg four times a day
Number of subjects: 32
Study: 7001230

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Carmustine (BCNU) plus radiotherapy
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Semustine (MeCCNU) plus radiotherapy
Number of subjects: 467
Study: 30844795

Group type: EXPERIMENTAL
Intervention: L-menthol spraying + Carbon Dioxide insufflation (n = 153)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: L-menthol spraying + Air insufflation (n = 156)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Carbon Dioxide insufflation (n = 153)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Air insufflation (n = 149)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: L-menthol spraying
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Carbon Dioxide insufflation
Number of subjects: 611
Study: 29502468

Group type: EXPERIMENTAL
Intervention: Cinitapride (CIN) single dose (1, 2, 4 tablets)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cinitapride (CIN) multiple dose (1 mg three times a day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cinitapride (CIN) single and multiple doses
Number of subjects: 12
Study: 27771748

Group type: EXPERIMENTAL
Intervention: 20 mg oral d-amphetamine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 20 mg oral d-amphetamine (G/A + G/G genotypes)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 26482675

Group type: EXPERIMENTAL
Intervention: Treatment of electrographic seizures (ESG)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Treatment of clinical seizures (CSG)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combined cohort (both ESG and CSG)
Number of subjects: 69
Study: 23371976

Group type: EXPERIMENTAL
Intervention: High-protein (HP) meals
Number of subjects: 11

Group type: COMPARATOR
Intervention: High-carbohydrate (HC) meals
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 11
Study: 21330401

Group type: EXPERIMENTAL
Intervention: Bevacizumab treatment
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study: 19524862

Group type: EXPERIMENTAL
Intervention: Comprehensive anemia care in CKD clinic
Number of subjects: 79

Group type: COMPARATOR
Intervention: Baseline QOL in CKD patients
Number of subjects: 79
Study: 18181515

Group type: EXPERIMENTAL
Intervention: S100b levels at the end of bypass (mean 0.30 microg/L, SD +/- 0.33, range 0.00 to 1.57)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: S100b levels at the end of bypass
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Neuropsychological battery of 9 tests administered 6-8 weeks post-operatively
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cerebral microemboli counts recorded by transcranial Doppler monitor
Number of subjects: 55
Study: 15055569

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 571
Study: 15497271

Group type: EXPERIMENTAL
Intervention: Instructional Program 1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Instructional Program 2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both Instructional Programs
Number of subjects: 60
Study: 9863091

Group type: EXPERIMENTAL
Intervention: Jianfei Pill (JFP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 7934346

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin (2500 IU daily)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Aspirin (300 mg) and dipyridamole (100 mg 8 hourly)
Number of subjects: 200
Study: 2888421

Group type: EXPERIMENTAL
Intervention: 50 micrograms sufentanil
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5 mg morphine
Number of subjects: 30
Study: 29754275

Group type: EXPERIMENTAL
Intervention: Zinc oxide eugenol paste (ZOE)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Iodoform paste (Guedes‐Pinto paste)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste thickened with zinc oxide
Number of subjects: 32

Group type: COMPARATOR
Intervention: No filling paste (control)
Number of subjects: 32
Study: 28394705

Group type: EXPERIMENTAL
Intervention: Fluad™ vaccination (Novartis, Italy) with a 5-visit schedule (day 0, 1/3, 7, 21, 70)
Number of subjects: 234
Study: 26022103

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT/MED)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Treatment as usual (TAU/MED)
Number of subjects: 95
Study: 22240615

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg kg(‐1)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg(‐1)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg kg(‐1)
Number of subjects: 140
Study: 21071270

Group type: EXPERIMENTAL
Intervention: Cetuximab (500 mg/m²), gemcitabine (1000 mg/m²), and oxaliplatin (100 mg/m²) every 2 weeks for 12 cycles
Number of subjects: 30
Study: 17349883

Group type: EXPERIMENTAL
Intervention: Taxus stent
Number of subjects: 3445

Group type: COMPARATOR
Intervention: Bare-metal stent
Number of subjects: 3445
Study: 16358378

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight-heparin (LMWH)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Unfractionated heparin (UH)
Number of subjects: 114
Study: 11942873

Group type: EXPERIMENTAL
Intervention: Acceleromyography (AMG) monitoring
Number of subjects: 120

Group type: COMPARATOR
Intervention: Clinical criteria without nerve stimulator
Number of subjects: 120
Study: 9616240

Group type: EXPERIMENTAL
Intervention: Grid in situ during fluoroscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Grid removed for fluoroscopy
Number of subjects: 0
Study: 7815675

Group type: EXPERIMENTAL
Intervention: Magnesium diglycinate (100 mg dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Magnesium oxide (MgO)
Number of subjects: 12
Study: 2698517

Group type: EXPERIMENTAL
Intervention: Intramuscular Delagil therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oral treatment
Number of subjects: 16
Study: 970386

Group type: EXPERIMENTAL
Intervention: Histamine acid phosphate at a dose of 76 mug/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Histamine acid phosphate at a dose of 3.2 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Histamine acid phosphate at various doses (40, 70, 76, 80 mug/kg and 3.2 mg)
Number of subjects: 20
Study: 30630341

Group type: EXPERIMENTAL
Intervention: Cangrelor (bolus followed by 2-hour infusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (bolus followed by 2-hour infusion)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cangrelor and Ticagrelor (180-mg loading dose administered as crushed tablets)
Number of subjects: 50
Study: 30322081

Group type: EXPERIMENTAL
Intervention: Whole cow-protein (WC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Whole goat-protein (WG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Partially-hydrolysed whey cow-protein (HC)
Number of subjects: 30
Study: 26839321

Group type: EXPERIMENTAL
Intervention: Betahistine 144 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 24876197

Group type: EXPERIMENTAL
Intervention: Care bundle to promote maternal breast milk (MBM) in the East of England (EoE)
Number of subjects: 144
Study: 22687509

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate (TR-701) 200, 300, or 400 mg orally once daily for 5 to 7 days
Number of subjects: 196

Group type: COMPARATOR
Intervention: Linezolid (Zyvox)
Number of subjects: 196
Study: 20128580

Group type: EXPERIMENTAL
Intervention: Torsional ultrasound (Infiniti Vision System; Alcon Laboratories, Fort Worth, TX)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Microburst with longitudinal ultrasound (Infiniti)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Microburst with longitudinal ultrasound (Legacy Everest, Alcon Laboratories)
Number of subjects: 360
Study: 17287635

Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg once daily)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Acenocoumarol
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 380
Study: 16249727

Group type: EXPERIMENTAL
Intervention: Erbium:YAG laser preparation of retrograde cavities
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasonic device preparation of retrograde cavities
Number of subjects: 60
Study: 12126250

Group type: EXPERIMENTAL
Intervention: Budesonide enema 2 mg/100 ml, administered twice daily (b.i.d.)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Budesonide enema twice weekly
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo enema
Number of subjects: 149
Study: 10216904

Group type: EXPERIMENTAL
Intervention: Filgrastim 10 micrograms kg-1 day-1
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Filgrastim 5 micrograms kg-1 day-1
Number of subjects: 46

Group type: COMPARATOR
Intervention: No PBSC collection
Number of subjects: 46
Study: 7618970

Group type: EXPERIMENTAL
Intervention: Selective decontamination (norfloxacin, colistin, amphotericin)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Selective decontamination
Number of subjects: 102
Study: 2487573

Group type: EXPERIMENTAL
Intervention: AZA-prednisolone regimen
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: CsA-prednisolone regimen
Number of subjects: 137
Study: 30522020

Group type: EXPERIMENTAL
Intervention: Combined treatment of high‐top boots and custom made rigid contoured carbon fibre foot orthoses
Number of subjects: 15
Study: 28881249

Group type: EXPERIMENTAL
Intervention: PET-CT-guided management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Broader NHS and PSS perspective of PET-CT management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (planned neck dissection)
Number of subjects: 0
Study: 26718510

Group type: EXPERIMENTAL
Intervention: SAPIEN XT
Number of subjects: 560

Group type: COMPARATOR
Intervention: SAPIEN
Number of subjects: 560
Study: 22820819

Group type: EXPERIMENTAL
Intervention: Combined 830-1064 nm LASER (radiating dose: 250 J cm‐2 delivered to the skin overlying the course of the median nerve at the wrist for 100 s at 25 W)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) (100 Hz, 30 minutes; rectangular waves; 80 ms width, intensity below muscle contraction)
Number of subjects: 20
Study: 20661545

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 19619920

Group type: EXPERIMENTAL
Intervention: 2 high-flux dialyzers in parallel for 4 hours
Number of subjects: 18
Study: 17612056

Group type: EXPERIMENTAL
Intervention: Essential omega-3 and omega-6 fatty acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 0
Study: 15598677

Group type: EXPERIMENTAL
Intervention: Hypocaloric high monounsaturated fat diet alone
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Exercise alone (EX)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Diet plus exercise (D+E)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (D intervention)
Number of subjects: 33
Study: 12433226

Group type: EXPERIMENTAL
Intervention: Grapefruit display (GD) symbology
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conventional inside-out HUD symbology
Number of subjects: 9

Group type: COMPARATOR
Intervention: Outside-in display symbology
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Front view orientation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Side view orientation
Number of subjects: 9
Study: 9810021

Group type: EXPERIMENTAL
Intervention: Sesame Street Fresh Apple Splash bubble bath
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nine children's liquid bubble bath solutions
Number of subjects: 0
Study: 7926528

Group type: EXPERIMENTAL
Intervention: Direct current electrocoagulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bipolar electrocoagulation
Number of subjects: 100
Study: 2556807

Group type: EXPERIMENTAL
Intervention: Nebulised nedocromil sodium 0.5 mg/ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebulised nedocromil sodium 5 mg/ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebulised nedocromil sodium 10 mg/ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebulised nedocromil sodium 20 mg/ml
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control run (no treatment)
Number of subjects: 10